Comparison the effect of 3 days with 7 days GNRH-antagonist in prevention of ovarian hyperstimulation syndrome(OHSS) in women undergoing assisted reproductive technology (ART)

Birjand University of Medical Sciences0 个研究点目标入组 40 人开始时间: 待定最近更新: 2021年11月29日

试验速览

暂无简介。

•Having informed consent to enter the study.
•The possibility of useful intervention on individuals.
•Age between 18 and 40 years.
•The person is at risk for OHSS syndrome (for example, the number of recovered eggs is more than 15 or serum estradiol more than 3000 pg / ml
•Any person who does not meet any of the exclusion criteria will be included in the study if satisfied

•Dissatisfaction to enter the study
•Age less than 18 years or more than 40 years
•Any disease that interferes with the intended intervention.
•Patient with diabetes / hemophilia or coagulation disorde
•Patients with pulmonary fibrosis, swelling or inflammation around the heart or lungs, high blood pressure, liver disease, heart valve disease, or allergy to cabergoline or ergot derivatives
•Use of drugs that affect the development of OHSS syndrome (calcium gluconate / metformin / letrozole / other GNRH-ant antagonists)
•Pregnancy during the study cycle
•Contraindications that are considered by a specialist and are not included in the test.

发起方